You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):獲得藥品GMP符合性檢查結果
格隆匯 02-03 16:28

格隆匯 2 月 3日丨華森製藥(002907.SZ)公佈,公司第五期新建GMP生產基地項目(“五期項目”)及原生產基地原料藥(鋁碳酸鎂)(三車間,鋁碳酸鎂二期合成生產線)於2020年接受並順利通過了重慶市藥品監督管理局(“市藥監局”)組織的藥品生產質量管理規範符合性檢查(“GMP符合性檢查”),並於近日陸續收到市藥監局核准簽發的上述相關生產線的《藥品生產質量管理規範符合性檢查結果的通知》,檢查結果為均符合《藥品生產質量管理規範》的有關規定。

公司此次獲得藥品GMP符合性檢查結果,表明公司相關生產線符合GMP要求,有利於公司繼續保持穩定的生產能力,滿足市場需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account